Definitive Contract HHSN272201700073C
Award Date 7/24/17
Potential Completion Date 7/31/18
Potential Value $224K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Afghanistan
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
12
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed Similar Awards
- This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Luna Innovations Incorporated, a small business, to develop Cytomegalovirus (CMV) Immunoglobulin G (IgG) and Immunoglobulin M (IgM) lateral flow assays required to support a large-scale CMV vaccination trial. The $1,499,994.00 award has a firm fixed price and is a Small Business Technology Transfer (STTR) Phase II contract with a...
- The U.S. Department of Health and Human Services (HHS) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $224,997.00 Small Business Innovation Research (SBIR) Phase I contract to Luna Innovations Incorporated for the development of a "Ligand Magneto Kit for Fast Modular Bacteria Collection." This definitive, firm fixed-price contract will be performed in Danville, Virginia and is scheduled for completion by July 31, 2016. Luna Innovations is a leading provider...
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a Small Business Innovation Research (SBIR) Phase I contract to Luna Innovations Incorporated, a leading provider of advanced fiber optic sensing and measurement systems. The contract, valued at $224,997, is for the development of "INNOVATIVE ORAL FORMULATIONS FOR ANTI-TB DRUGS." This Firm Fixed Price contract has an ultimate completion date of August 25, 2017. Luna Innovations, a for-profit manufacturer, is...
- This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Luna Innovations Incorporated, a for-profit organization and manufacturer of goods. The $149,998.00 contract is for the multiplex detection of recent and prior exposure to pathogens, and was awarded on September 15, 2019 with a completion date of March 14, 2020. The contract is not a set-aside. Luna Innovations is a technology company that...
- This is a Small Business Innovation Research (SBIR) contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Luna Labs USA LLC, a subsidiary of Luna Innovations Incorporated. The $599,993.00 firm fixed-price contract is for developing "Reagents for Immunologic Analysis of Non-Mammalian and Underrepresented Mammalian Models." This SBIR contract is set aside for small businesses and supports NIAID's mission...
- This is a $224,953.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Luna Innovations Incorporated, a small business manufacturer, under the SBIR program. The contract is for the development and delivery of a "Magnetic Microparticle Kit for Cell Removal from Blood" and has a period of performance ending on August 17, 2016. This contract is for Phase I research and development under the SBIR program, which supports small...
- This is a $299,998.00 definitive contract awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Luna Innovations Incorporated, a for-profit manufacturer of goods. The contract is for a firm fixed price and does not have a set-aside designation. Based on Luna Innovations' background, the contract likely involves the provision of specialized optical and sensing instruments, fiber optic technologies, and...
- This is a $222,693 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services. The prime contractor is Zymeron Corporation, a minority-owned small business biotechnology company based in North Carolina. Under this contract, Zymeron will investigate the use of lateral flow immunoassays to rapidly determine the serostatus of individuals for cytomegalovirus (CMV) infections. The...
- This is a $150,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Luna Innovations Incorporated, a for-profit manufacturer. The contract is a firm fixed price purchase order with a completion date of March 1, 2019. As an SBIR Phase I award, this contract supports early-stage research and development of innovative technologies, products, or services that could ultimately...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Small Business Innovation Research (SBIR) Phase II contract to Luna Innovations Incorporated, a manufacturer of goods, for the development of "Innovative Oral Formulations for Anti-TB Drugs". The firm-fixed-price contract, with a potential value of $1,499,796.00, was awarded on August 28, 2018, and is set to be completed by November 30, 2020. As a...